Resverlogix Corp.

(RVX:APH)

By |

Profile

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing RVX-208, a molecule selective inhibit BET domain inhibitor for the treatment of patients with cardiovascular, diabetes mellitus, Alzheimer\'s & chronic kidney disease.

Contact Information

Website: www.resverlogix.com
Email: sarah@resverlogix.com
Main Phone: +1 403 254-9252
Address: 4820 Richard Road S.W.
Address 2: Suite 300
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T3E 6L1

Issuer Information

Exchange: TSX
Employees: 22
NAICS: Biological Produ
$ 1.40 $ 0.02 (1.45%)
Last Price 1.40 Change $ 0.02 Change % 1.45 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 1.42 High 1.44 Low 1.40 Prev Close 1.38
Last Trade Volume 1,600 52 Wk Hi 2.45 52 Wk Low 1.26
Market Cap 248.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 177,181,992.00 EPS (TTM) -0.66 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5 5 5 5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 07/29/16 07/29/16 07/29/16 07/29/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1